HMB-45: A Review

Applied Immunohistochemistry and Molecular Morphology

Volumn 4, Issue 2, 1996, Pages 73-85

  Bacchi, Carlos E ^a,c   Bonetti, Franco ^b   Pea, Maurizio ^b   Martignoni, Guido ^b   Gown, Allen M ^c  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Angiomyolipoma; HMB 45; Immunohistochemistry; Lymphangiomyomatosis; Melanoma; Melanosomes; Sugar tumor; Tuberous sclerosis

Indexed keywords

MONOCLONAL ANTIBODY;

ANGIOMYOLIPOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; LYMPHANGIOMYOMA; MELANOMA; MELANOSOME; PRIORITY JOURNAL; REVIEW; TUBEROUS SCLEROSIS;

EID: 0029902611     PISSN: 10623345     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (123)

1. Gown AM, Vogel AM, Hoak D, Gough F, McNutt MA. Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes. Am J Pathol 1986; 123:195-203.
2. Colombari R, Bonetti F, Zamboni G, et al. Distribution of melanoma specific antibody (HMB-45) in benign and malignant melanocytic tumours. An immunohistochemical study on paraffin sections. Virchows Arch A Pathol Anal Histopathol 1988;413:17-24.
3. Ordoñez NG, Ji XL, Hickey RC. Comparison of HMB-45 monoclonal antibody and S-100 protein in the immunohistochemical diagnosis of melanoma. Am J Clin Pathol 1988; 90:385-90.
4. Wick MR, Swanson PE, Rocamora A. Recognition of malignant melanoma by monoclonal antibody HMB-45. An immunohistochemical study of 200 paraffin-embedded cutaneous tumors. J Cutan Pathol 1988;15:201-7.
5. Bonetti F, Pea M, Martignoni G, et al. Clear cell ("sugar") tumor of the lung is a lesion strictly related to angiomyolipoma - the concept of a family of lesions characterized by the presence of the perivascular epithelioid cells (PEC). Pathology 1994;26:230-6.
6. Gal AA, Koss MN, Hochholzer L, Chejfec G. An immunohistochemical study of benign clear cell ('sugar') tumor of the lung. Arch Pathol Lab Med 1991;115:1034-8.
7. el-Naggar AK, Ordoñez NG, Sara A, McLemore D, Batsakis JG. Clear cell sarcomas and metastatic soft tissue melanomas. A flow cytometric comparison and prognostic implications. Cancer 1991;67:2173-9.
8. Fernandez PL, Cardesa A, Bombi JA, Palacin A, Traserra J. Malignant sinonasal epithelioid schwannoma. Virchows Arch A Pathol Anat Histopathol 1993;423:401-5.
9. Ekfors TO, Kujari H, Isomaki M. Clear cell sarcoma of tendons and aponeuroses (malignant melanoma of soft parts) in the duodenum: the first visceral case. Histopathology 1993;22:255-9.
10. Mechtersheimer G, Tilgen W, Klar E, Moller P. Clear cell sarcoma of tendons and aponeuroses: case presentation with special reference to immunohistochemical findings. Hum Pathol 1989;20:914-7.
11. Swanson PE, Wick MR. Clear cell sarcoma. An immunohistochemical analysis of six cases and comparison with other epithelioid neoplasms of soft tissue. Arch Pathol Lab Med 1989;113:55-60.
12. Bonetti F, Colombari R, Manfrin E, et al. Breast carcinoma with positive results for melanoma marker (HMB-45). HMB-45 immunoreactivity in normal and neoplastic breast. Am J Clin Pathol 1989;92:491-5.
13. Bonetti F, Pea M, Martignoni G, et al. False-positive immunostaining of normal epithelia and carcinomas with ascites fluid preparations of antimelanoma monoclonal antibody HMB-45: Am J Clin Pathol 1991;95:454-9.
14. Walts AE, Said JW, Shintaku IP. Cytodiagnosis of malignant melanoma. Immunoperoxidase staining with HMB-45 antibody as an aid to diagnosis. Am J Clin Pathol 1988;90: 77-80.
15. Kapur RP, Bigler SA, Skelly M, Gown AM. Anti-melanoma monoclonal antibody HMB-45 identifies an oncofetal glycoconjugate associated with immature melanosomes. J Histochem Cytochem 1992;40:207-12.
16. Schaumburg-Lever G, Metzler G, Kaiserling E. Ultrastructural localization of HMB-45 binding sites. J Cutan Pathol 1991;18:432-5.
17. Steuhl KP, Rohrbach JM, Knorr M, Thiel HJ. Significance, specificity, and ultrastructural localization of HMB-45 antigen in pigmented ocular tumors. Ophthalmology 1993; 100:208-15.
18. Taatjes DJ, Arendash-Durand B, von-Turkovich M, Trainer TD. HMB-45 antibody demonstrates melanosome specificity by immunoelectron microscopy. Arch Pathol Lab Med 1993;117:264-8.
19. Esclamado RM, Gown AM, Vogel AM. Unique proteins defined by monoclonal antibodies specific for human melanoma. Some potential clinical applications. Am J Surg 1986;152:376-85.
20. Adema GJ, de-Boer AJ, van-'t-Hullenaar R, et al. Melanocyte lineage-specific antigens recognized by monoclonal antibodies NKI-beteb, HMB-50, and HMB-45 are encoded by a single cDNA. Am J Pathol 1993;143:1579-85.
21. Adema GJ, de-Boer AJ, Vogel AM, Loenen WA, Figdor CG. Molecular characterization of the melanocyte lineage-specific antigen gp100. J Biol Chem 1994;269:20126-33.
22. Vennegoor C, Hageman P, Van-Nouhuijs H, et al. A monoclonal antibody specific for cells of the melanocyte lineage. Am J Pathol 1988;130:179-92.
23. Kwon BS. Pigmentation genes: the tyrosinase gene family and the pmel 17 gene family. J Invest Dermatol 1993;100: 134S-40S.
24. Kobayashi T, Urabe K, Orlow SJ, et al. The Pmel 17/silver locus protein. Characterization and investigation of its melanogenic function. J Biol Chem 1994;269:29198-205.
25. Wagner SN, Wagner C, Hofler H, Atkinson MJ, Goos M. Expression cloning of the cDNA encoding a melanoma-associated ag recognized by mAb HMB-45: Identification as a melanocyte-specific Pmel 17 cDNA, Lab Invest 1995; 73:229-35.
26. Smoller BR, Hsu A, Krueger J. HMB-45 monoclonal antibody recognizes an inducible and reversible melanocyte cytoplasmic protein. J Cutan Pathol 1991;18:315-22.
27. Holbrook KA, Underwood RA, Vogel AM, Gown AM, Kimball H. The appearance, density and distribution of melanocytes in human embryonic and fetal skin revealed by the anti-melanoma monoclonal antibody, HMB-45. Anat Embryol Berl 1989;180:443-55.
28. Pettinato G, Manivel JC, d'Amore ES, Jaszcz W, Gorlin RJ. Melanotic neuroectodermal tumor of infancy. A reexamination of a histogenetic problem based on immunohistochemical, flow cytometric, and ultrastructural study of 10 cases. Am J Surg Pathol 1991;15:233-45.
29. Skelton HG3, Smith KJ, Barrett TL, Lupton GP, Graham JH. HMB-45 staining in benign and malignant melanocytic lesions. A reflection of cellular activation. Am J Dermatopathol 1991;13:543-50.
30. Clemmensen OJ, Fenger C. Melanocytes in the anal canal epithelium. Histopathology 1991;18:237-41.
31. Palazzo JP, Duray PH. Congenital agminated Spitz nevi: immunoreactivity with a melanoma-associated monoclonal antibody. J Cutan Pathol 1988;15:166-70.
32. Ahmed I, Piepkorn M, Goldgar DE, et al. HMB-45 staining of dysplastic melanocytic nevi in melanoma risk groups. J Cutan Pathol 1991;18:257-60.
33. Paul E, Illig L. Histochemical investigations of dermal nevus cells. (Fluorescence histochemistry of Falck-Hillarp and enzyme histochemistry.) Arch Dermatol Forsch 1974; 251:133-45.
34. Natali PG, Cavaliere R, Matsui M, Buraggi G, Callgano L, Ferrone S. Human melanoma associated antigens identified with monoclonal antibodies: characterization and potential clinical application. In: Ruiten DJ, Welvaart K, Ferrone S, eds. Cutaneous melanoma and precursor lesions. Boston: Martinus Nijhoff Publishers, 1984:19-38.
35. Burnier MN Jr, McLean IW, Gamel JW. Immunohistochemical evaluation of uveal melanocytic tumors. Expression of HMB-45, S-100 protein, and neuron-specific enolase. Cancer 1991;68:809-14.
36. McDonnell JM, Sun YY, Wagner D. HMB-45 immunohistochemical staining of conjunctival melanocytic lesions. Ophthalmology 1991;98:453-8.
37. Gazit D, Daniels TE. Oral melanocytic lesions: differences in expression of HMB-45 and S-100 antigens in round and spindle cells of malignant and benign lesions. J Oral Pathol Med 1994;23:60-4.
38. Glasgow BJ, McCall LC, Foos RY. HMB-45 antibody reactivity is pigmented lesions of the conjunctiva. Am J Ophthalmol 1990;109:696-700.
39. Smoller BR, McNutt NS, Hsu A. HMB-45 staining of dysplastic nevi. Support for a spectrum of progression toward melanoma. Am J Surg Pathol 1989;13:680-4.
40. Lampert A, Thomine E, Lauret P, Hemet J. Comparative study of HMB-45 monoclonal antibody uptake on various benign and malignant melanocytic lesions. Ann Pathol 1993;13:100-7.
41. Clark WH Jr, Elder DE, Guerry D4, Epstein MN, Greene MH, Van-Horn M. A study of tumor progression: the prev cursor lesions of superficial spreading and nodular melanoma. Hum Pathol 1984;15:1147-65.
42. Bortolani A, Barisoni D, Scomazzoni G. Benign "metastatic" cellular blue nevus. Ann Plast Surg 1994;33:426-31.
43. Rupee R, Eckert F, Ruzicka T. Malignant blud nevus. Hautarzt 1993;44:164-6.
44. Sun J, Morton TH Jr, Gown AM. Antibody HMB-45 identifies the cells of blue nevi. As immunohistochemical study on paraffin sections. Am J Surg Pathol 1990;14:748-51.
45. Wood WS, Tron VA. Analysis of HMB-45 immunoreactivity in common and cellular blue nevi. J Cutan Pathol 1991; 18:261-3.
46. Barnhill RL, Mihm MC Jr, Magro CM. Plexiform spindle cell naevus: a distinctive variant of plexiform melanocytic naevus. Histopathology 1991;18:243-7.
47. Fernando SS, Johnson S, Bate J. Immunohistochemical analysis of cutaneous malignant melanoma: comparison of S-100 protein, HMB-45 monoclonal antibody and NKI/C3 monoclonal antibody. Pathology 1994;26:16-9.
48. Anstey A, Cerio R, Ramnarain N, Orchard G, Smith N, Jones EW. Desmoplastic malignant melanoma. An immunocytochemical study of 25 cases. Am J Dermatopathol 1994;16:14-22.
49. Carlson JA, Dickersin GR, Sober AJ, Barnhill RL. Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases. Cancer 1995;75:478-94.
50. Nakhleh RE, Wick MR, Rocamora A, Swanson PE, Dehner LP. Morphologic diversity in malignant melanomas. Am J Clin Pathol 1990;93:731-40.
51. Prieto VG, Kanik A, Salob S, McNutt NS. Primary cutaneous myxoid melanoma: immunohistologic clues to a difficult diagnosis. J Am Acad Dermatol 1994;30:335-9.
52. Sheibani K, Battifora H. Signet-ring cell melanoma. A rare morphologic variant of malignant melanoma. Am J Surg Pathol 1988;12:28-34.
53. Mowat A, Reid R, Mackie R. Balloon cell metastatic melanoma: an important differential in the diagnosis of clear cell tumours. Histopathohgy 1994;24:469-72.
54. Habeck JO. Primary malignant melanoma of the gallbladder. Case report and literature review. Zentralbl Pathol 1993;139:367-71.
55. Sielezneff I, Boutboul R, Thomas P, Henric A, Denis O. Primary anorectal malignant melanomas. 2 cases. Presse Med 1993;22:1999-2001.
56. Mourad VVA, Mackay B, Ordoñez NG, Ro JY, Swanson DA. Clear cell melanoma of the bladder. Ultrastruct Pathol 1993;17:463-8.
57. Lucas DR, Tazelaar HD, Unni KK, et al. Osteogenic melanoma. A rare variant of malignant melanoma. Am J Surg Pathol 1993;17:400-9.
58. Bacchi CE, Goldfogel GA, Greer BE, Gown AM. Paget's disease and melanoma of the vulva. Use of a panel of monoclonal antibodies to identify cell type and to microscopically define adequacy of surgical margins. Gynecol Oncol 1992;46:216-21.
59. Carstens PH, Hollander JL. Metastatic spindle cell malignant melanoma with prominent microvilli. Ultrastruct Pathol 1992;16:587-91.
60. Franquemont DW, Mills SE. Sinonasal malignant melanoma. A clinicopathologic and immunohistochemical study of 14 cases. Am J Clin Pathol 1991;96:689-97.
61. Wick MR, Stanley SJ, Swanson PE. Immunohistochemical diagnosis of sinonasal melanoma, carcinoma, and neuroblastoma with monoclonal antibodies HMB-45 and antisynaptophysin. Arch Pathol Lab Med 1988;112:616-20.
62. Santoso JT, Kucera PR, Ray J. Primary malignant melanoma of the uterine cervix: two case reports and a century's review. Obstet Gynecol Surv 1990;45:733-40.
63. Fitzgibbons PL, Chaurushiya PS, Nichols PW, Chandrasoma PT, Martin SE. Primary mucosal malignant melanoma: an immunohistochemical study of 12 cases with comparison to cutaneous and metastatic melanomas. Hum Pathol 1989;20:269-72.
64. Donner LR, Manriquez M, Greene JF Jr. Minimal deviation spindle cell melanoma: unusual histologic pattern in an 11-year-old black girl. Pediatr Pathol 1988;8:401-7.
65. Chang ES, Wick MR, Swanson PE, Dehner LP. Metastatic malignant melanoma with "rhabdoid" features. Am J Clin Pathol 1994;102:426-31.
66. Cohen RE, Weaver MG, Montenegro HD, Abdul-Karim FW. Pulmonary blastoma with malignant melanoma component. Arch Pathol Lab Med 1990;114:1076-8.
67. Robinson JK. Margin control for lentigo maligna. J Am Acad Dermatol 1994;31:79-85.
68. Stonecipher MR, Leshin B, Patrick J, White WL. Management of lentigo maligna and lentigo maligna melanoma with paraffin-embedded tangential sections: utility of immunoperoxidase staining and supplemental vertical sections. J Am Acad Dermatol 1993;29:589-94.
69. Gown AM, Vogel AM. Monoclonal antibodies to human intermediate filament proteins. II. Distribution of filament proteins in normal human tissues. Am J Pathol 1984;114: 309-21.
70. Kamino H, Tam ST. Immunoperoxidase technique modified by counterstain with azure B as a diagnostic aid in evaluating heavily pigmented melanocytic neoplasms. J Cutan Pathol 1991;18:436-9.
71. Tsang WY, Chan JK, Chow LT. Signet-ring cell melanoma mimicking adenocarcinoma. A case report. Acta Cytol 1993;37:559-62.
72. Simmons TJ, Martin SE. Fine-needle aspiration biopsy of malignant melanoma: a cytologic and immunocytochemical analysis. Diagn Cytopathol 1991;7:380-6.
73. Ordoñez NG, Sneige N, Hickey RC, Brooks TE. Use of monoclonal antibody HMB-45 in the cytologic diagnosis of melanoma. Acta Cytol 1988;32:684-8.
74. Nasiell K, Tani E, Skoog L. Fine needle aspiration cytology and immunocytochemistry of metastatic melanoma. Cytopathology 1991;2:137-47.
75. Leong AS-Y, Milios J. An assessment of a melanoma-specific antibody (HMB-45) and other immunohistochemical markers of malignant melanoma in paraffin embedded tissues. Surgical Pathology 1989;2:137-45.
76. Abu-Alfa AK, Straus FH II, Montag AG. An immunohistochemical study of thyroid Hurthle cells and their neoplasms: the roles of S-100 and HMB-45 proteins. Mod Pathol 1994;7:529-32.
77. Bishop PW, Menasce LP, Yates AJ, Win NA, Banerjee SS. An immunophenotypic survey of malignant melanomas. Histopathology 1993;23:159-66.
78. Fraga M, Garcia-Caballero T, Antunez J, Couce M, Beiras A, Forteza J. A comparative immunohistochemical study of phaeochromocytomas and paragangliomas. Histol Histopathol 1993;8:429-36.
79. Mehregan AH, Mehregan DR, Broecker A. Epithelioid cell histiocytoma. A clinicopathologic and immunohistochemical study of eight cases. J Am Acad Dermatol 1992;26: 243-6.
80. Bacchi CE, Gown AM. Specificity of antibody HMB-45. Arch Pathol Lab Med 1992;116:899-900.
81. Iyer PV, Leong AS. Poorly differentiated squamous cell carcinomas of the skin can express vimentin. J Cutan Pathol 1992;19:34-9.
82. Ma CK, Zarbo RJ, Gown AM. Immunohistochemical characterization of atypical fibroxanthoma and dermatofibrosarcoma protuberans. Am J Clin Pathol 1992;97:478-83.
83. Visscher D, Cooper PH, Zarbo RJ, Crissman JD. Cutaneous neuroendocrine (Merkel cell) carcinoma: an immunophenotypic, clinicopathologic, and flow cytometric study. Mod Pathol 1989;2:331-8.
84. Yates AJ, Banerjee SS, Bishop PW, Graham KE. HMB-45 in non-melanocytic tumours. Histopathology 1993;23: 477-8.
85. Kanitakis J, Hermier C, Chouvet B, Thivolet J. Reactivity of HMB-45 monoclonal antibody with sweat-gland tumours of the skin. Acta Derm Venereol (Stockh) 1991;71:426-8.
86. Chetty R, Clark SP. HMB-45 staining in pigmented pheochromocytoma. Arch Pathol Lab Med 1992;116:1102-3.
87. Unger PD, Hoffman K, Thung SN, Pertsemlides D, Wolfe D, Kaneko M. HMB-45 reactivity in adrenal pheochromocytomas. Arch Pathol Lab Med 1992;116:151-3.
88. Laforga JB, Aranda FI. HMB-45 reactivity in sustentacular cells of paragangliomas. Histopathology 1994;24:199.
89. Zimmer C, Gottschalk J, Goebel S, Cervos-Navarro J. Melanoma-associated antigens in tumours of the nervous system: an immunohistochemical study with the monoclonal antibody HMB-45. Virchows Arch A Pathol Anat Histopathol 1992;420:121-6.
90. Petruch UR, Horny HP, Kaiserling E. Frequent expression of haemopoietic and non-haemopoietic antigens by neoplastic plasma cells: an immunohistochemical study using formalin-fixed, paraffin-embedded tissue. Histopathology 1992;20:35-40.
91. Wang JH, Dhillon AP, Sankey EA, Wightman AK, Lewin JF, Scheuer PJ. 'Neuroendocrine' differentiation in primary neoplasms of the liver. J Pathol 1991;163:61-7.
92. Walker WP, Landas SK, Bromley CM, Sturm MT. Immunohistochemical distinction of classic and chondroid chordomas. Mod Pathol 1991;4:661-6.
93. Hancock C, Allen BC, Herrera GA. HMB-45 detection in adenocarcinomas. Arch Pathol Lab Med 1991;115:886-90.
94. Friedman HD, Tatum AH. HMB-45-positive malignant lymphoma. A case report with literature review of aberrant HMB-45 reactivity. Arch Pathol Lab Med 1991;115:826-30.
95. Guillou L, Lamoureux E, Masse S, Costa J Alveolar softpart sarcoma of the uterine corpus: histological, immunocytochemical and ultrastructural study of a case. Virchows Arch A Pathol Anat Histopathol 1991;418:467-71.
96. Kornstein MJ, Franco AP. Specificity of HMB-45. Arch Pathol Lab Med 1990;114:450.
97. Ruck P, Kaiserling E. Melanin-containing hepatoblastoma with endocrine differentiation. An immunohistochemical and ultrastructural study. Cancer 1993;72:361-8.
98. Shimizu S, Teraki Y, Ishiko A, et al. Malignant epithelioid schwannoma of the skin showing partial HMB-45 positivity. Am J Dermatopathol 1993;15:378-84.
99. Gal AA, Koss MN, Hochholzer L, DeRose PB, Cohen C. Pigmented pulmonary carcinoid tumor. An immunohistochemical and ultrastructural study. Arch Pathol Lab Med 1993;117:832-6.
100. Gomez MR. Phenotypes of the tuberous sclerosis complex with a revision of diagnostic criteria. Ann NY Acad Sci 1991;615:1-7.
101. Pea M, Bonetti F, Zamboni G, et al. Melanocyte-marker-HMB-45 is regularly expressed in angiomyolipoma of the kidney. Pathology 1991;23:185-8.
102. Tsui WM, Yuen AK, Ma KF, Tse CC. Hepatic angiomyolipomas with a deceptive trabecular pattern and HMB-45 reactivity. Histopathology 1992;21:569-73.
103. Ashfaq R, Weinberg AC, Albores-Saavedra J. Renal angiomyolipomas and HMB-45 reactivity. Cancer 1993;71: 3091-7.
104. Weeks DA, Chase DR, Malott RL, Zuppan CW, Beckwith JB, Mierau GW. HMB-45 staining in angiomyolipoma, cardiac rhabdomyoma, other mesenchymal processes and tuberous sclerosis-associated brain lesions. J Surg Pathol 1994;1:191-8.
105. Tallarigo C, Baldassarre R, Bianchi G, et al. Diagnostic and therapeutic problems in multicentric renal angiomyolipoma. J Urol 1992;148:1880-4.
106. Weeks DA, Malott RL, Arnesen M, Zuppan C, Aitken D, Mierau G. Hepatic angiomyolipoma with striated granules and positivity with melanoma - specific antibody (HMB-45): a report of two cases. Ultrastruct Pathol 1991;15:563-71.
107. Kaiserling E, Krober S, Xiao JC, Schaumburg-Lever G. Angiomyolipoma of the kidney. Immunoreactivity with HMB-45. Light- and electron-microscopic findings. Histopathology 1994;25:41-8.
108. Bonetti F, Pea M, Martignoni G, Zamboni G. PEC and sugar [Letter; Comment]. Am J Surg Pathol 1992;16:307-8.
109. Bonetti F, Pea M, Martignoni G, Zamboni G, Iuzzolino P. Cellular heterogeneity in lymphangiomyomatosis of the lung [Letter; Comment]. Hum Pathol 1991;22:727-8.
110. Bonetti F, Chiodera PL, Pea M, et al. Transbronchial biopsy in lymphangiomyomatosis of the lung. HMB-45 for diagnosis. Am J Surg Pathol 1993;17:1092-102.
111. Bonetti F, Chiodera P, Pea M, Zamboni G. Transbronchial biopsy in pulmonary lymphangiomyomatosis. Am J Surg Pathol 1995;19:241-2.
112. Minda JMG, Dessy E, Pietra GG. Immunogold localization of HMB-45 antigen in pulmonary lymphangiomyomatosis. In: Proceedings of the Microscopy Society of America Annual Meeting, Kansas City, MO, 1995.
113. Chan JK, Tsang WY, Pau MY, Tang MC, Pang SW, Fletcher CD. Lymphangiomyomatosis and angiomyolipoma: closely related entities characterized by hamartomatous proliferation of HMB-45-positive smooth muscle. Histopathology 1993;22:445-55.
114. Hoon V, Thung SN, Kaneko M, Unger PD. HMB-45 reactivity in renal angiomyolipoma and lymphangioleiomyomatosis. Arch Pathol Lab Med 1994;118:732-4.
115. Liebow AA, Castleman B. Benign clear cell ("sugar") tumors of the lung. Yale J Biol Med 1971;43:213-22.
116. Chiodera PL, Pea M, Martignoni G, Bonetti F. Pulmonary lymphangiomyomatosis associated with miliariform "sugar". Int J Surg Pathol 1995;2:(suppl):483.
117. Pea M, Bonetti F, Zamboni G, Martignoni G, Fiore-Donati I, Doglioni C. Clear cell tumor and angiomyolipoma. Am J Surg Pathol 1991;15:199-202.
118. Gaffey MJ, Mills SE, Zarbo RJ, Weiss LM, Gown AM. Clear cell tumor of the lung. Immunohistochemical and ultrastructural evidence of melanogenesis. Am J Surg Pathol 1991;15:644-53.
119. Bonetti F, Pea M, Martignoni G. A myoendocrine cell expressing melanoma-related antigens links together the visceral lesions of tuberous sclerosis syndroma. Mod Pathol 1993;6:120A.
120. Martignoni G, Pea M, Bonetti F, et al. Renal epithelioid oxyphilic neoplasms (REON). A pleomorphic variant of renal angiomyolipoma. Int J Surg Pathol 1994;2(suppl):539.
121. Bonzanini M, Pea M, Martignoni G, et al. Preoperative diagnosis of renal angiomyolipoma: fine needle aspiration cytology and immunocytochemical characterization. Pathology 1994;26:170-5.
122. Bonetti F, Pea M, Martignoni G, Bonzanini M. Sarcomatoid tumors of the kidney. Diagn Cytopathol 1994;10:305-6.
123. Ma TK, Tse MK, Tsui WM, Yuen KT. Fine needle aspiration diagnosis of angiomyolipoma of the liver using a cell block with immunohistochemical study. A case report. Acta Cytol 1994;38:257-60.